Entities / Company
Regulus Therapeutics.
Biopharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 11
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Regulus Therapeutics this week
News at the entities that move Regulus Therapeutics most-
Novartis StructuralNovartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Moves Regulus Therapeutics
Connections
The 1 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Novartis Structural
Novartis acquired Regulus Therapeutics, establishing it as a subsidiary to expand its biopharmaceutical portfolio.